CA2789252C - Streptococcus pyogenes antigens and corresponding dna fragments - Google Patents

Streptococcus pyogenes antigens and corresponding dna fragments Download PDF

Info

Publication number
CA2789252C
CA2789252C CA2789252A CA2789252A CA2789252C CA 2789252 C CA2789252 C CA 2789252C CA 2789252 A CA2789252 A CA 2789252A CA 2789252 A CA2789252 A CA 2789252A CA 2789252 C CA2789252 C CA 2789252C
Authority
CA
Canada
Prior art keywords
polypeptide
ala
gly
lys
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2789252A
Other languages
English (en)
French (fr)
Other versions
CA2789252A1 (en
Inventor
Denis Martin
Bernard R. Brodeur
Josee Hamel
Stephane Rioux
Patrick Rheault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Publication of CA2789252A1 publication Critical patent/CA2789252A1/en
Application granted granted Critical
Publication of CA2789252C publication Critical patent/CA2789252C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0208Specific bacteria not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
CA2789252A 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments Expired - Fee Related CA2789252C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
US60/256,940 2000-12-21
CA2432525A CA2432525C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2432525A Division CA2432525C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (2)

Publication Number Publication Date
CA2789252A1 CA2789252A1 (en) 2002-06-27
CA2789252C true CA2789252C (en) 2016-11-15

Family

ID=22974225

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2789252A Expired - Fee Related CA2789252C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments
CA2432525A Expired - Fee Related CA2432525C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2432525A Expired - Fee Related CA2432525C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Country Status (12)

Country Link
US (5) US7595057B2 (enExample)
EP (1) EP1343895B1 (enExample)
JP (1) JP4080876B2 (enExample)
AT (1) ATE398677T1 (enExample)
AU (2) AU1686302A (enExample)
BE (1) BE2021C506I2 (enExample)
BR (1) BR0116704A (enExample)
CA (2) CA2789252C (enExample)
DE (1) DE60134494D1 (enExample)
ES (1) ES2307564T3 (enExample)
FR (1) FR21C1005I2 (enExample)
WO (1) WO2002050107A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
WO2024206953A2 (en) * 2023-03-29 2024-10-03 Taktos Therapeutics Inc. Ides variant proteins and methods of using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
ES2278436T3 (es) * 1998-02-20 2007-08-01 Id Biomedical Corporation Antigenos de estreptococos del grupo b.
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
JP2002531055A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌のタンパク質及び核酸分子
JP2002531054A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド B群連鎖球菌由来の核酸およびタンパク質
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
AU2002210301A1 (en) * 2000-10-13 2002-04-22 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
ES2338637T3 (es) * 2001-02-21 2010-05-11 Id Biomedical Corporation Polipeptidos de streptococcus pyogenes y fragmentos de adn correspondiente.
US20040236072A1 (en) * 2001-04-13 2004-11-25 Olmsted Stephen Bruce Surface proteins of streptococcus pyogenes
CA2453062C (en) * 2001-07-06 2013-04-02 Shire Biochem Inc. Group b streptococcus bvh-a5 antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
AU2002351623A1 (en) * 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
AU2003246495A1 (en) * 2002-07-15 2004-02-02 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
PL1901773T3 (pl) * 2005-06-09 2012-09-28 Hansa Medical Ab Zastosowanie proteinazy IDES (Z S. Pyogenes) do leczenia chorób autoimmunologicznych oraz odrzutów przeszczepu
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
DK2190984T3 (da) * 2007-09-14 2013-12-02 Genovis Ab Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
US20100119507A1 (en) 2010-05-13
AU2002216863B2 (en) 2008-02-28
AU1686302A (en) 2002-07-01
US20040097706A1 (en) 2004-05-20
US8298551B2 (en) 2012-10-30
AU2002216863B8 (en) 2008-03-20
ATE398677T1 (de) 2008-07-15
ES2307564T9 (es) 2021-04-26
US8821895B2 (en) 2014-09-02
US7595057B2 (en) 2009-09-29
JP2004524014A (ja) 2004-08-12
CA2432525C (en) 2012-11-27
WO2002050107A2 (en) 2002-06-27
CA2789252A1 (en) 2002-06-27
EP1343895A2 (en) 2003-09-17
WO2002050107A3 (en) 2003-04-10
US20160326221A1 (en) 2016-11-10
BR0116704A (pt) 2003-12-23
DE60134494D1 (de) 2008-07-31
CA2432525A1 (en) 2002-06-27
BE2021C506I2 (enExample) 2021-05-31
US20150017684A1 (en) 2015-01-15
ES2307564T3 (es) 2008-12-01
FR21C1005I1 (enExample) 2021-03-26
JP4080876B2 (ja) 2008-04-23
US9340586B2 (en) 2016-05-17
EP1343895B1 (en) 2008-06-18
US20130136760A1 (en) 2013-05-30
FR21C1005I2 (fr) 2022-01-14

Similar Documents

Publication Publication Date Title
WO2003054007A2 (en) Streptococcus antigens
US20080038268A1 (en) Streptococcus Pyogenes Antigens
US7883706B2 (en) Methods for using Streptococcus pyogenes polypeptides
US9340586B2 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
AU2002234455A1 (en) Streptococcus pyogenes polypeptides and corresponding DNA fragments
EP2025754A2 (en) Moraxella (Branhamella) catarrhalis antigens
AU2002302236A1 (en) Moraxella(Branhamella) catarrhalis antigens
AU2001272270B2 (en) Streptococcus pyogenes antigen
WO2004007725A1 (en) Polypeptide of streptococcus pyogenes
WO2002079475A2 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU2001272270A1 (en) Streptococcus pyogenes antigen

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20171221